首页>Advances in therapy.>Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension
Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension
作者单位:Department of Clinical and Molecular Medicine, University of Rome la Sapienza, Sant'Andrea Hospital[1]Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona, Barcelona, Spain[2]Daiichi Sankyo Europe GmbH, Munich, Germany[3]